SENP1 Aberrance and Its Linkage to Clinical Features, Adjuvant Regimen, and Prognosis in Patients With Surgical Non-small Cell Lung Cancer Receiving Adjuvant Chemotherapy

SENP1 Aberrance and Its Linkage to Clinical Features, Adjuvant Regimen, and Prognosis in Patients With Surgical Non-small Cell Lung Cancer Receiving Adjuvant Chemotherapy

BackgroundSmall ubiquitin-like modifier-specific protease 1 (SENP1) plays vital roles in cancer progression and chemoresistance, but its prognostic value in non-small cell lung cancer (NSCLC) is vague. This study aimed to explore the correlation of SENP1 with clinical features, adjuvant chemotherapy...

Full description

Bibliographic Details
Main Authors: Qian Yang, Mengmeng Yang, Jun Zhang, Yuquan Ma
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Surgery
Subjects:
small ubiquitin-like modifier-specific protease 1
surgical non-small cell lung cancer
clinical features
adjuvant chemotherapy regimen
prognosis
Online Access:https://www.frontiersin.org/articles/10.3389/fsurg.2021.771785/full

Internet

https://www.frontiersin.org/articles/10.3389/fsurg.2021.771785/full

Similar Items